PRIA Logo™
119-hr-10859119th Congress

Biotech Defense Act

Sponsored By: Representative Biggs, Sheri [R-SC-3]

Introduced

Summary

Make biotechnology threats a formal part of U.S. defense strategy. The bill focuses on risks from the People’s Republic of China (PRC) and would create interagency assessments, a Biotechnology Risk Assessment Contact Group, and required congressional reporting.

Show full summary
  • Defense planners: Would require the Secretary of Defense to integrate biotechnology-threat considerations into the National Defense Strategy and Defense Planning Guidance and to publish a strategy that assesses adversary capabilities and lists countermeasures. The Director of National Intelligence would deliver a comprehensive assessment of PRC military biotechnology within 180 days.
  • Biotech companies and investors: Would create a contact group to monitor foreign investments and partnerships in the U.S. biotech sector, track entities with PRC ties in a database, and coordinate reviews with the Committee on Foreign Investment in the United States.
  • Congress and partners: Would mandate regular unclassified reports plus a classified annex option to specified congressional committees and periodic briefings on the contact group’s activities at least every 90 days to inform oversight and international coordination.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Biggs, Sheri [R-SC-3]

SC • R

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation